Why Lo Lo?
Lo Loestrin Fe is the only birth control pill that provides effective pregnancy prevention with the lowest amount of daily estrogen (10 micrograms) available.1 It’s the low-dose birth control pill prescribed to over 3 million women.3
When you’re taking Lo Loestrin Fe, you may experience short, lighter periods. In fact, some women found their period lasted less than 2 days per cycle on average, and most women had periods that were lighter than normal.1,2
* IQVIA™. TRx by Specialty: January 2018 - July 2018 (claim derived from the use of information under license from IQVIA, which expressly reserves all rights, including rights of copying, distribution, and republication).
‡ Please click here to see Program Terms, Conditions, and Eligibility Criteria. Maximum savings limit applies; patient out-of-pocket expense may vary. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs.
Why choose Lo Loestrin Fe?
Lo Loestrin Fe is an ultra-low-dose pill, an option for many women who are looking for effective pregnancy prevention with a low dose of estrogen.1
What’s in Lo Loestrin Fe?
Lo Loestrin Fe contains a low-dose combination of two female hormones. The hormones are an estrogen called ethinyl estradiol and a progestin called norethindrone acetate.1
How many of the pills contain hormones?
Lo Loestrin Fe has 26 days of "active" pills that contain hormone(s) and 2 days of "reminder" pills that do not contain hormones. These types of birth control pills are sometimes called extended-regimen pills.1
What are the side effects, like weight change?
In a clinical study, 4% of women reported changes in weight when taking Lo Loestrin Fe. The most common side effects reported by women taking Lo Loestrin Fe were nausea/vomiting (7%), headache (7%), spotting or bleeding between menstrual periods (5%), painful menstruation (4%), weight change (4%), breast tenderness (4%), acne (3%), abdominal pain (3%), anxiety (2%) and depression (2%).
How can you get started?
A survey of more than 1000 current and potential birth control pill users found that†:
† Online survey conducted by The Harris Poll on behalf of Allergan, between July 7–14, 2014 among 1005 U.S. women age 18–45 currently using oral contraceptives (OCs) or considering use in the next 6 months.
§ Survey respondents could choose from the following to indicate their interest in an OC with the lowest amount of daily estrogen: extremely interested, very interested, somewhat interested, and not at all interested. The 93% value represents those who answered extremely interested, very interested, and somewhat interested.
|| Survey respondents could choose from the following to indicate their level of worry about the amount of hormones they are exposed to through the use of OCs: extremely worried, very worried, somewhat worried and not at all worried. The 78% value represents those who answered extremely worried, very worried, and somewhat worried.